Donovan Quill

The value of a patient-first approach and telehealth for addressing the complex health care coordination needs of patients with rare pulmonary diseases has never been more critical than during the COVID-19 pandemic.

Specialty pharmacists give physicians and specialists the opportunity to focus less on non-medical issues and more on the patient and efficiently finding the most optimal therapy.

When it comes to maximizing therapeutic opportunities for the treatment of individuals with toxoplasmosis, pharmacists and other health care professionals understand the value of care coordination.

Health care practitioners and manufacturers must change practice patterns and management strategies.

This model focuses sharply on orphan diseases to better address the patient experience, outcomes, and requirements of each study.

A recent poll showed that more than 1 in 8 Americans engaged in a video consult with a health care professional in recent months.

When telehealth is part of a larger personalized care plan tied specifically to a particular specialty drug, pharmacists can be better positioned to empower their patients.